bpc 157 patent Teva Pharmaceuticals owns a key BPC-157 — and they're too busy making Adderall to care. That's why there's no trial. #BPC157 #Peptides #BigPharma #Patents #Biohacking bpc 157 peptide tendonitis Multifunctionality

That single gap in counseling has quietly affected the fertility of countless men who simply wanted to feel like themselves again

Mild, temporary redness or itchiness can occur, especially on sensitive skin

Do not use Mounjaro if you are allergic to it or any of the ingredients in Mounjaro

Injection-site and quality-control risk Reported injection-site issues include redness, mild swelling, transient bruising, and occasional sterile abscess

Participants on the 5mg dose lost an average of 16.0% of their body weight

Standard therapies possess extensive, long-term safety data and profound cardiovascular benefits that make them the gold standard for initiating treatment